翻訳と辞書 |
Initiative for Global Access to Medicines : ウィキペディア英語版 | Initiative for Global Access to Medicines The Initiative for Global Access to Medicines (IGAM) is a McMaster University-based organization that actively works to improve access to medicine through mobilizing Canadian politicians and stakeholders. They are known for advocating in favor of low-cost legislative interventions which incentivize the research, development and distribution of pharmaceutical products targeting rare and neglected diseases. They have also spoken in favor reforming Canada's Access to Medicines Regime (CAMR) and have worked to promote the Health Impact Fund (HIF). ==Previous and current work== As of November 2013, IGAM's main project involves advocating for a Priority Review Voucher (PRV) system in Canada.〔Rachel Faber. (2013). Health Science students take learning outside the classroom. The Silhouette. ()〕〔Nicole Jedrzejko, Christina Park, Zain Rizvi. (2013). Stimulating Canadian research and development for lifesaving medicines; the Priority Review Voucher. ()〕 The system has been previously implemented in the United States. In 2013, the organization had talks with members of Health Canada and the Canadian Organization for Rare Disorders to discuss inserting legislation into the upcoming Canada Orphan Drug Framework scheduled to be passed in early 2014. The organization has also spoken in favor of reforming the Canadian Access to Medicines Regime, which it argues is ineffective.〔Steven Hoffman and Zain Rizvi. (2013). Ten years of failure to provide medicine. ()〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Initiative for Global Access to Medicines」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|